Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125019) titled 'Lipoic acid adjuvant therapy for sepsis-associated acute intestinal dysfunction: a single-center, randomized, single-blind, placebo-controlled phase II clinical trial' on May 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Suzhou Ninth People's Hospital
Condition:
Sepsis-Associated Intestinal Injury
Intervention:
ALA group:Intravenous infusion of lipoic acid at a dose of 600mg once a day for 7 consecutive days
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-22
Target Sample Size: ALA group:88;Control group :88;
Countries of Recruitment:
Chi...